Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Post by RisePrize007on Jan 19, 2021 7:12pm
169 Views
Post# 32330137

Aion Therapeutic Files Five Patents with the United States P

Aion Therapeutic Files Five Patents with the United States PAion Therapeutic Inc. (CSE:AION) (“Aion Therapeutic” or the “Company”) is pleased to announce that the Company has filed five patent applications with the United States Patent and Trademark Office (USPTO) pertaining to new treatments combining healing compounds in medical cannabis with healing compounds from mushrooms (edible and psychedelic), and other natural plants known for their medicinal properties. These patent applications have formulation claims directed to methods of treating numerous conditions including cancer, psychiatric disorders, addiction (opioid and alcohol), viral diseases, obesity, and inflammatory disorders. These first five patents are just the beginning of what the Company expects to be a full portfolio of intellectual property including blocking patents designed to protect Aion Therapeutic’s discoveries.

 

The backbone of the Company’s combinatorial treatment formulation discovery platform is artificial intelligence (AI) techniques. Using AI, the Company intends to create a full line of therapeutic products that includes combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as, individualized treatments for personalized medicine using human genome and other data unique to an individual.

  • Findings suggest combinations of medical cannabis-based compounds and medical mushroom-derived compounds can be used to treat diseases including cancer, psychiatric diseases (including depression, PTSD, and anxiety), addiction (opioid and alcohol), viral diseases, obesity, and inflammatory disorders.
  • Patent applications filed to protect these findings will be a significant addition to Aion Therapeutic’s global intellectual property portfolio.

The titles of these five patent applications are:

  1. Compositions and Methods for Treatment of Cancers;
  2. Compositions and Methods for Treatment of Psychoses and Psychotic Disorders;
  3. Antiviral Compositions and Methods for Their Use;
  4. Compositions and Methods for Treatment of Inflammation; and
  5. Compositions and Methods for Promoting Weight Loss and For Treatment of Obesity.
Read more here/Source: https://investingnews.com/news/psychedelics-investing/aion-therapeutic-files-five-patents-with-the-united-states-patent-and-trademark-office/
<< Previous
Bullboard Posts
Next >>